Molecular Therapy (2011) 19 2, 219–220. doi:10.1038/mt.2010.307
Seppo Ylä-Herttuala
Deputy Editor, and President (2011–2012), European Society of Gene and Cell Therapy
Good summary of recent advances in gene therapy, lists of the most important achievements in this field of knowledge over the past year and shows the growing interest of pharmaceutical companies in hereditary diseases, including many rare diseases.
Thursday, February 3, 2011
Subscribe to:
Posts (Atom)
